Literature DB >> 28384754

A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.

Gillian J Buckley1, Brian L Strom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28384754     DOI： 10.7326/M17-0766

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

1.  Elimination of Hepatitis B and C Virus Infections.

Authors:  Andrew Aronsohn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-04

2.  A Multi-Fidelity Rollout Algorithm for Dynamic Resource Allocation in Population Disease Management.

Authors:  Ting-Yu Ho; Shan Liu; Zelda B Zabinsky
Journal:  Health Care Manag Sci       Date:  2018-09-07

3.  Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.

Authors:  Meghan D Morris; Ali Mirzazadeh; Jennifer L Evans; Alya Briceno; Phillip Coffin; Judith A Hahn; Kimberly A Page
Journal:  Drug Alcohol Depend       Date:  2019-02-27       Impact factor: 4.492

4.  Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding.

Authors:  Andrew M Moon; Pamela K Green; Don C Rockey; Kristin Berry; George N Ioannou
Journal:  Aliment Pharmacol Ther       Date:  2019-11-27       Impact factor: 8.171

5.  Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.

Authors:  H Jensie Burton; Aastha Khatiwada; Dongjun Chung; Eric G Meissner
Journal:  South Med J       Date:  2022-06       Impact factor: 0.810

Review 6.  Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.

Authors:  Allison E Wang; Eric Hsieh; Barbara J Turner; Norah Terrault
Journal:  J Gen Intern Med       Date:  2022-04-28       Impact factor: 6.473

7.  Ethnic Disparities in Chronic Hepatitis B Infection: African Americans and Hispanic Americans.

Authors:  Kimberly A Forde
Journal:  Curr Hepatol Rep       Date:  2017-05-22

8.  Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.

Authors:  Juan Berenguer; Inmaculada Jarrín; Leire Pérez-Latorre; Víctor Hontañón; María J Vivancos; Jordi Navarro; María J Téllez; Josep M Guardiola; José A Iribarren; Antonio Rivero-Juárez; Manuel Márquez; Arturo Artero; Luis Morano; Ignacio Santos; Javier Moreno; María C Fariñas; María J Galindo; María A Hernando; Marta Montero; Carmen Cifuentes; Pere Domingo; José Sanz; Lourdes Domíngez; Oscar L Ferrero; Belén De la Fuente; Carmen Rodríguez; Sergio Reus; José Hernández-Quero; Gabriel Gaspar; Laura Pérez-Martínez; Coral García; Lluis Force; Sergio Veloso; Juan E Losa; Josep Vilaró; Enrique Bernal; Sari Arponen; Amat J Ortí; Ángel Chocarro; Ramón Teira; Gerardo Alonso; Rafael Silvariño; Ana Vegas; Paloma Geijo; Josep Bisbe; Herminia Esteban; Juan González-García
Journal:  Open Forum Infect Dis       Date:  2018-01-12       Impact factor: 3.835

9.  Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians.

Authors:  Sandeep T Samuel; Anthony D Martinez; Yang Chen; Marianthi Markatou; Andrew H Talal
Journal:  World J Hepatol       Date:  2018-02-27

10.  Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Authors:  Phillip O Coffin; Glenn-Milo Santos; Emily Behar; Jaclyn Hern; John Walker; Tim Matheson; Elizabeth N Kinnard; Janelle Silvis; Eric Vittinghoff; Rena Fox; Kimberley Page
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.